| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.18 | 4e-09 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.17 | 3e-07 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.14 | 7e-07 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-06 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.17 | 6e-06 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.17 | 8e-06 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.13 | 1e-05 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.13 | 2e-05 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.14 | 4e-05 |